Student Dies and Over 50 Hospitalised in Andhra Pradesh After Taking Anti-Malaria Tablets

In Brief

1. A student died and over 50 others were hospitalised in Andhra Pradesh after consuming anti-malaria tablets.
2. The medication involved was chloroquine, distributed during a health drive.
3. State health authorities launched an investigation to inspect drug safety and batch quality.
4. Officials are closely monitoring affected individuals and assessing potential contamination or adverse drug reactions.

A student in Andhra Pradesh has died and over 50 people have been hospitalised after consuming anti-malaria tablets. The medication involved was chloroquine, an antiparasitic drug routinely used to treat malaria by increasing toxic heme levels within malarial parasites.

Health officials responded swiftly following reports of severe adverse reactions across the affected area. Authorities have initiated a formal inquiry and collected samples from the drug batch to pinpoint the exact cause of the fatality and widespread hospitalisations.

Preliminary assessments point toward potential contamination, substandard drug quality, or acute adverse reactions, though official laboratory results remain pending. The tragedy has raised significant concerns over pharmaceutical quality control and drug safety protocols in the state.

Medical teams continue to monitor hospitalised patients, and public health officials have advised residents to report to health centers immediately if they experience discomfort after taking distributed medications.